Literature DB >> 6481164

Naturally occurring autoantibodies to exoplasmic and cryptic regions of band 3 protein, the major integral membrane protein of human red blood cells.

H U Lutz, R Flepp, G Stringaro-Wipf.   

Abstract

Immunoglobulin G (IgG) of healthy human blood donors and IgG from pooled sera (Sandoglobulin) contain natural (auto)antibodies to band 3 protein, the major integral membrane protein of human red blood cells. Affinity-purified and 125I-iodinated anti-band 3 antibodies bound specifically to band 3 protein on immunoblots from membrane proteins in the presence of unlabeled, absorbed IgG. Purified (auto)antibodies also bound nonspecifically to band 4.2 and weakly to band 5 and 6, when assayed with second antibody and 125I-iodinated protein A. The antibodies were directed to regions of band 3 protein that were cryptic and in part exoplasmic but with a low accessibility to surface modifications. The antigenic sites were located within the 65K, but not the 38K-dalton chymotryptic fragment of band 3 protein. Antigenic band 3 protein was equally present in membranes of young and senescent red cells. Hence, if these antibodies were involved in recognizing a few exoplasmic sites of band 3 protein on senescent red cells, antigen exposure would require alterations in band 3 accessibility (conformation, topology) rather than an enzymatic generation of antigenic sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481164

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Comment Concerning the Role of CD47 and Signal Regulatory Protein Alpha in Regulating the Clearance of Aged Red Blood Cells.

Authors:  Hans U Lutz
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

2.  Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells.

Authors:  Hans U Lutz
Journal:  Transfus Med Hemother       Date:  2012-08-27       Impact factor: 3.747

3.  Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes.

Authors:  K Schlüter; D Drenckhahn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes.

Authors:  S M Waugh; B M Willardson; R Kannan; R J Labotka; P S Low
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Red cell associated, naturally occurring anti-spectrin antibodies.

Authors:  H U Lutz; R Flepp; P Stammler; R Baccalà
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Re-evaluation of the structural integrity of red-cell glycoproteins during aging in vivo and nutrient deprivation.

Authors:  A Brovelli; C Seppi; A Bardoni; C Balduini; H U Lutz
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

7.  Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction.

Authors:  U Galili; M R Clark; S B Shohet
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes.

Authors:  H U Lutz; F Bussolino; R Flepp; S Fasler; P Stammler; M D Kazatchkine; P Arese
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Expression of senescent antigen on erythrocytes infected with a knobby variant of the human malaria parasite Plasmodium falciparum.

Authors:  E Winograd; J R Greenan; I W Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.